Clinical Trial CTSUBREC40603-M
Title
Randomized Phase II 2 X 2 Factorial Trial Of The Addition Of Carboplatin +/- Bevacizumab To Neoadjuvant Weekly Paclitaxel Followed By Dose-Dense AC In Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer
Principal Investigator(s)
John Murray
Details
- Protocol No. CTSUBREC40603-M
- Open Date: 12/07/2010
- Staging: Phase II
- Age Group: Adults
- Scope: National
- Objective:
- Disease Sites: Breast
- Therapies: Chemotherapy - cytotoxic
- Drugs: None Specified
- Participating Institutions: Baptist Hospital; Meharry Medical College
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
